Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Inventory Average (2018 - 2025)

Agios Pharmaceuticals' Inventory Average history spans 7 years, with the latest figure at $32.5 million for Q4 2025.

  • For Q4 2025, Inventory Average rose 20.19% year-over-year to $32.5 million; the TTM value through Dec 2025 reached $32.5 million, up 20.19%, while the annual FY2025 figure was $30.3 million, 29.65% up from the prior year.
  • Inventory Average reached $32.5 million in Q4 2025 per AGIO's latest filing, up from $31.4 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $32.5 million in Q4 2025 to a low of $3.3 million in Q2 2022.
  • Average Inventory Average over 4 years is $19.5 million, with a median of $21.1 million recorded in 2024.
  • Peak YoY movement for Inventory Average: skyrocketed 313.22% in 2023, then grew 20.19% in 2025.
  • A 4-year view of Inventory Average shows it stood at $6.8 million in 2022, then skyrocketed by 165.95% to $18.2 million in 2023, then soared by 48.68% to $27.0 million in 2024, then rose by 20.19% to $32.5 million in 2025.
  • Per Business Quant, the three most recent readings for AGIO's Inventory Average are $32.5 million (Q4 2025), $31.4 million (Q3 2025), and $30.2 million (Q2 2025).